Vastal Pharmaceuticals Private Limited
About Vastal Pharmaceuticals Private Limited
Data last updated:
Vastal Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 07 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51397UP2003PTC028053. Its GSTIN is 09AABCV9405A1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pooja Chaudhary and Tarun Chaudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 – A Samrat Enclaveopposite Ram Purna Gas Agency Garh Road Meerut, Uttar Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.74 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.82 Lakh (net margin 0.4%) and EBITDA of ₹3.51 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 18% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vastal Pharmaceuticals Private Limited's registered office is in Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address24 – A Samrat Enclaveopposite Ram Purna Gas Agency Garh Road Meerut, Uttar Pradesh, India
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Vastal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vastal Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vastal Pharmaceuticals Private Limited, buy the company report.
Financials of Vastal Pharmaceuticals Private Limited
FY 2025 filings availableVastal Pharmaceuticals Private Limited reported revenue of ₹4.74 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 8% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vastal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vastal Pharmaceuticals Private Limited
Vastal Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Chaudhary | Director | 07 Nov 2003 | 22 Years 11 Months | Current |
| Tarun Chaudhary | Director | 07 Nov 2003 | 22 Years 11 Months | Current |
Peer comparison
Vastal Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Westin Pharmaceuticals Private Limited | ₹4.77 Cr (FY 2025) | 12.0% | Karnal, Haryana, India | |||
| Vastal Pharmaceuticals Private Limitedthis company | ₹4.74 Cr (FY 2025) | ₹1.82 Lakh | 0.4% | 8.0% | 9 | Uttar Pradesh, India |
| Axodin Pharmaceuticals Private Limited | ₹4.72 Cr (FY 2025) | 7.0% | Ambala, Haryana, India | |||
| Bis Marck Pharmaceuticals Private Limited | ₹4.68 Cr (FY 2025) | 28.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Vastal Pharmaceuticals Private Limited, buy the company report.
Auditor
Vastal Pharmaceuticals Private Limited is audited by Rajeev Devendra & co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajeev Devendra & co | FY 2023 | 013719C |
Shareholding
The shareholding of Vastal Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vastal Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vastal Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vastal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vastal Pharmaceuticals Private Limited has a workforce of 9 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Vastal Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCV9405A1ZJ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vastal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vastal Pharmaceuticals Private Limited has 2 board changes on record since 2003: 2 appointments. The latest: Pooja Chaudhary was appointed as Director on 07 Nov 2003.
Frequently asked questions
Vastal Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 07 November 2003 (23+ years old) and is registered under CIN U51397UP2003PTC028053.
Vastal Pharmaceuticals has 2 current directors:
- Pooja Chaudhary - Director
- Tarun Chaudhary - Director
The latest financial statements of Vastal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vastal Pharmaceuticals is 09AABCV9405A1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Vastal Pharmaceuticals is U51397UP2003PTC028053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vastal Pharmaceuticals was incorporated on 07 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Vastal Pharmaceuticals by revenue are Westin Pharmaceuticals Private Limited, Axodin Pharmaceuticals Private Limited, Bis Marck Pharmaceuticals Private Limited, all in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pooja Chaudhary was appointed as Director on 07 Nov 2003. Tarun Chaudhary was appointed as Director on 07 Nov 2003.
The registered office of Vastal Pharmaceuticals is at 24 – A Samrat Enclaveopposite Ram Purna Gas Agency Garh Road Meerut, Uttar Pradesh, India.
Vastal Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Vastal Pharmaceuticals is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.